Welcome to the
Hepatitis B Foundation
Three New Studies Help Clarify Optimal Use of Combination Therapy in Chronic Hepatitis B Patients
April 14 - Three new studies presented at the International Liver Congress 2014 have helped clarify the optimal use of combination therapy with peginterferon and nucleoside analogues to achieve the best treatment outcomes in patients with chronic hepatitis B. Read more.
Viral Hepatitis More Deadly Than HIV in Europe
April 14 Mortality from viral hepatitis is significantly higher than from HIV/AIDS across European Union (EU) countries, according to results from The Global Burden of Disease Study 2010, which was announced for the first time at the International Liver Congress 2014. Read more.
Small Cash Incentives Dramatically Improve Hepatitis B Vaccination Rates Among Injecting Drug Users
April 14 Modest financial incentives significantly improve adherence to hepatitis B virus vaccination programs among patients receiving opioid dependence treatment, according to a study published in The Lancet. Read more.
New Marker to Predict Recurrence of Hepatocellular Carcinoma
April 14 High preoperative levels of hepatitis B surface antigen (HBsAg) in patients with a low viral load predict an increased likelihood of hepatocellular carcinoma recurrence after resection, Chinese researchers report. Read more.
Saving Lives Through Prevention: Ensuring Equal Access for All
April 14 During National Public Health Week, Chari Cohen, HBFs Director of Public Health discussed the success of current public health prevention programs, and the need to ensure all communities have equal access to preventive services. Read more.
Hep B United Participates in Launch of Updated HHS Viral Hepatitis Action Plan
April 3 A launch event was held today in Wash, DC to announce the renewed viral hepatitis action plan from U.S. Dept. of Health and Human Services (HHS) which was first released in May 2011 with a keynote address from U.S. Secretary for Health Kathleen Sebelius. The renewed plan, which was spearheaded by Dr. Howard Koh, HHS Assistant Secretary for Health, provides critical steps to improve the prevention of viral hepatitis and the care and treatment of those who are infected, and lists important actions the agencies will undertake between 2014 and 2016 across six priority areas. Ms. Chari Cohen, HBF Director for Public Health, was invited to participate on the Community Panel during this event. Read more.
Page last modified April 14, 2014